Ningbo David Medical Device Co., Ltd. (SHE:300314)
China flag China · Delayed Price · Currency is CNY
12.78
-0.12 (-0.93%)
Sep 29, 2026, 11:30 AM CST

SHE:300314 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
578.86578.62516.93606.83496.58469.87
Other Revenue
5.825.4110.111.479.464.26
584.68584.03527.03618.3506.04474.13
Revenue Growth
14.09%10.82%-14.76%22.18%6.73%3.18%
Cost of Revenue
295.11273.01233.47263.61210.28185.25
Gross Profit
289.56311.02293.55354.68295.76288.88
Selling, General & Admin
169.93174.81172.44172.15155.19166.5
Research & Development
56.559.355.4648.0645.8749.69
Other Operating Expenses
10.494.565.036.727.986.81
Operating Expenses
237.06239.96233.16227.43210.26223.27
Operating Income
52.5171.0660.39127.2585.565.61
Interest Expense
-0.33-0.43-0.47-0.6-0.35-0.03
Interest & Investment Income
21.3525.8410.7125.875.3918.9
Currency Exchange Gain (Loss)
-22.12-5.720.836.3317.05-2.86
Other Non Operating Income (Expenses)
-0.09-0.48-0.46-0.3-0.27-0.23
EBT Excluding Unusual Items
51.3390.2771.01158.55107.3181.38
Impairment of Goodwill
---0.52-1.53--
Gain (Loss) on Sale of Investments
5.961.78-10.060.26-4.880.69
Gain (Loss) on Sale of Assets
-0.27-0.39-0.01-0.230.020.12
Asset Writedown
-0.01-0.02-0.01-0.08-0.02-0.04
Other Unusual Items
10.087.022.989.249.495.05
Pretax Income
67.0898.6663.38166.22111.9287.19
Income Tax Expense
6.9211.66.1218.6114.566.99
Net Income
60.1687.0557.26147.6197.3680.21
Net Income to Common
60.1687.0557.26147.6197.3680.21
Net Income Growth
-2.51%52.02%-61.21%51.62%21.39%-41.11%
Shares Outstanding (Basic)
290290286289286286
Shares Outstanding (Diluted)
290290286289286286
Shares Change
1.39%1.35%-1.08%1.08%-0.04%-1.14%
EPS (Basic)
0.210.300.200.510.340.28
EPS (Diluted)
0.210.300.200.510.340.28
EPS Growth
-3.84%50.00%-60.78%50.00%21.43%-40.43%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
53.9234.22-45.8294.8161.7944.95
Free Cash Flow Per Share
0.190.12-0.160.330.220.16
Dividend Per Share
0.0800.0800.0870.1800.1500.100
Dividend Growth
-8.05%-8.05%-51.67%20.00%50.00%-33.33%
Gross Margin
49.53%53.25%55.70%57.36%58.45%60.93%
Operating Margin
8.98%12.17%11.46%20.58%16.89%13.84%
Profit Margin
10.29%14.91%10.87%23.87%19.24%16.92%
Free Cash Flow Margin
9.22%5.86%-8.70%15.33%12.21%9.48%
EBITDA
73.8692.4884.68154.57108.9389.76
EBITDA Margin
12.63%15.83%16.07%25.00%21.53%18.93%
D&A For EBITDA
21.3521.4124.2927.3223.4324.15
EBIT
52.5171.0660.39127.2585.565.61
EBIT Margin
8.98%12.17%11.46%20.58%16.89%13.84%
Effective Tax Rate
10.31%11.76%9.65%11.20%13.01%8.01%
Revenue as Reported
584.68584.03527.03618.3506.04474.13
Advertising Expenses
-9.383.224.513.324.06